CD274 and colorectal carcinoma: For example, the host immune response to TMB was very different between patients with dMMR/MSI-H CRC and those with pMMR/MSI-L CRC (76, 94), and a single anti-PD-1/PD-L1 mAbs could not block all the regulatory pathways/signals.